Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study)

Ophthalmology. 2016 Jun;123(6):1399-401. doi: 10.1016/j.ophtha.2015.12.012. Epub 2016 Jan 9.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage
  • Bevacizumab / administration & dosage*
  • Dexamethasone / administration & dosage*
  • Diabetic Retinopathy / complications
  • Diabetic Retinopathy / drug therapy*
  • Dose-Response Relationship, Drug
  • Drug Implants
  • Female
  • Follow-Up Studies
  • Glucocorticoids / administration & dosage
  • Humans
  • Intravitreal Injections
  • Macular Edema / drug therapy*
  • Macular Edema / etiology
  • Male
  • Time Factors
  • Treatment Outcome
  • Visual Acuity*

Substances

  • Angiogenesis Inhibitors
  • Drug Implants
  • Glucocorticoids
  • Bevacizumab
  • Dexamethasone